← Back to Search

Network Interventions for Living Kidney Donation

N/A
Recruiting
Research Sponsored by Penn State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adults aged 18 or older
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 years
Awards & highlights

Study Summary

This trial will survey transplant candidates and their families/friends to understand the barriers to volunteering and evaluation for a kidney transplant. They will also examine how different network characteristics are associated with eventual living donor kidney transplant outcomes.

Who is the study for?
This trial is for adults over 18 who are kidney transplant candidates or part of their network at the University of Pennsylvania or University of Alabama-Birmingham. Participants must be able to consent and speak English. It's not open to those outside these networks or under 18.Check my eligibility
What is being tested?
The study tests two interventions, Search Intervention and Script Intervention, aimed at reducing barriers in finding living kidney donors. It involves surveying transplant candidates and their networks, analyzing how social connections affect donor outcomes.See study design
What are the potential side effects?
Since this trial focuses on surveys and educational interventions rather than medical treatments, traditional physical side effects are not applicable. However, participants may experience stress or emotional discomfort discussing sensitive health issues.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 3 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Approvals for living kidney donor candidacy
Completed living kidney donor evaluations
Completed living kidney donor screening questionnaires
+4 more
Secondary outcome measures
Concerns about living kidney donation
Kidney
Preference for living kidney donor
+3 more

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Search InterventionExperimental Treatment1 Intervention
This group will complete the candidate survey, refer members of their family and social network for participation in a web survey, and be given information about the statistical likelihood that each member of their social network will be free of contraindications for living kidney donation.
Group II: Script InterventionExperimental Treatment1 Intervention
This group will complete the survey, refer members of their family and social network for participation in a web survey, and review a set of suggested talking points and an example script to guide discussion of potential living donation with members of their network.
Group III: Both Search and Script InterventionExperimental Treatment2 Interventions
This group will complete the candidate survey, refer members of their family and social network for participation in a web survey, be given information about the statistical likelihood that each member of their social network will be free of contraindications for living kidney donation, and review a set of suggested talking points and an example script to guide discussion of potential living donation with members of their network.
Group IV: No interventionActive Control1 Intervention
This group will only complete study survey and refer members of their family and social network for participation in a web survey.

Find a Location

Who is running the clinical trial?

Penn State UniversityLead Sponsor
353 Previous Clinical Trials
125,421 Total Patients Enrolled
University of PennsylvaniaOTHER
1,994 Previous Clinical Trials
42,878,943 Total Patients Enrolled
University of Alabama at BirminghamOTHER
1,573 Previous Clinical Trials
2,272,979 Total Patients Enrolled

Media Library

Search Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05255757 — N/A
Kidney Disease Research Study Groups: No intervention, Script Intervention, Search Intervention, Both Search and Script Intervention
Kidney Disease Clinical Trial 2023: Search Intervention Highlights & Side Effects. Trial Name: NCT05255757 — N/A
Search Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05255757 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What overarching goals is this medical research aiming to achieve?

"During the 3 year span of this trial, researchers aim to measure a range of outcomes concerning living kidney donation. These include how religious beliefs influence an individual's willingness to donate a kidney, survey responses gauging participants' readiness for kidney transplantation prior and post intervention, and lastly self-assessed knowledge regarding such transplants."

Answered by AI

Are there any available positions in this experiment for participants?

"Data on clinicaltrials.gov affirms that this medical trial is presently enlisting volunteers, with the original posting being made on October 12th 2021 and a recent update occurring July 13th 2022."

Answered by AI

How many individuals have the opportunity to join this medical experiment?

"Affirmative. Clinicaltrials.gov holds records of this research which was initially posted on October 12th 2021 and recently updated on July 13th 2022. The study will recruit 300 individuals from two separate locations for participation in the trial."

Answered by AI
~0 spots leftby Apr 2024